{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:07:58Z","timestamp":1792098478383,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T00:00:00Z","timestamp":1499817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.msard.2017.07.014","type":"journal-article","created":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T16:01:10Z","timestamp":1499788870000},"page":"116-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Patient perspectives on neuromyelitis optica spectrum disorders: Data from the PatientsLikeMe online community"],"prefix":"10.1016","volume":"17","author":[{"given":"Stephanie","family":"Eaneff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Hanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen A.","family":"Mealy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander U.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Eek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"Ratchford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Nyberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Goodall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Wicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2017.07.014_bib1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/archneurol.2007.16","article-title":"Cognitive functions in neuromyelitis optica","volume":"65","author":"Blanc","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2017.07.014_bib2","doi-asserted-by":"crossref","first-page":"e59707","DOI":"10.1371\/journal.pone.0059707","article-title":"Evaluation of an online platform for multiple sclerosis research: patient description, validation of severity scale, and exploration of BMI effects on disease course","volume":"8","author":"Bove","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2017.07.014_bib3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrneurol.2014.129","article-title":"Pain in neuromyelitis optica \u2013 prevalence, pathogenesis and therapy","volume":"10","author":"Bradl","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2017.07.014_bib4","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1468-1331.2010.03252.x","article-title":"Evaluation of health-related quality of life, fatigue and depression in neuromyelitis optica","volume":"18","author":"Chanson","year":"2011","journal-title":"Eur. J. Neurol."},{"issue":"P6","key":"10.1016\/j.msard.2017.07.014_bib5","first-page":"155","article-title":"Pain, fatigue and depression in patients with neuromyelitis optica spectrum disorder in Europe and USA","volume":"86","author":"Chavarro","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2017.07.014_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/WNF.0000000000000131","article-title":"The efficacy and tolerability of mycophenolate mofetil in treating neuromyelitis optica and neuromyelitis optica spectrum disorder in Western China","volume":"39","author":"Chen","year":"2016","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.msard.2017.07.014_bib7","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/01.WNL.0000159399.81861.D5","article-title":"An open label study of the effects of rituximab in neuromyelitis optica","volume":"64","author":"Cree","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2017.07.014_bib8","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.2196\/jmir.5130","article-title":"Exploring concordance of patient-reported information on PatientsLikeMe and medical claims data at the patient level","volume":"18","author":"Eichler","year":"2016","journal-title":"J. Med. Internet Res."},{"key":"10.1016\/j.msard.2017.07.014_bib9","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ana.24617","article-title":"Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2017.07.014_bib10","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1001\/jamaneurol.2014.2057","article-title":"Mycophenolate mofetil in the treatment of neuromyelitis optica spectrum disorder","volume":"71","author":"Huh","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.msard.2017.07.014_bib11","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/archneurol.2009.175","article-title":"Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients","volume":"66","author":"Jacob","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2017.07.014_bib12","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1007\/s00415-008-0910-y","article-title":"Employment in multiple sclerosis. Exiting and re-entering the work force","volume":"255","author":"Julian","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2017.07.014_bib13","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2017.07.014_bib14","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1212\/WNL.51.4.1219","article-title":"Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine","volume":"51","author":"Mandler","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2017.07.014_bib15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.7224\/1537-2073.2012-048","article-title":"The incidence and prevalence of neuromyelitis optica: a systematic review","volume":"15","author":"Marrie","year":"2013","journal-title":"Int. J. MS Care"},{"key":"10.1016\/j.msard.2017.07.014_bib16","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/archneurol.2012.314","article-title":"Epidemiology of neuromyelitis optica in the United States: a multicenter analysis","volume":"69","author":"Mealy","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2017.07.014_bib17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jns.2015.11.031","article-title":"Cognitive and psychiatric comorbidities in neuromyelitis optica","volume":"360","author":"Moore","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2017.07.014_bib18","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.3109\/09638288.2013.833301","article-title":"Life on hold: the experience of living with neuromyelitis optica","volume":"36","author":"Mutch","year":"2014","journal-title":"Disabil. Rehabil."},{"key":"10.1016\/j.msard.2017.07.014_bib19","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1177\/1352458515572406","article-title":"Demographic and clinical features of neuromyelitis optica: a review","volume":"21","author":"Pandit","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2017.07.014_bib20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrneurol.2014.141","article-title":"Treatment of neuromyelitis optica: state-of-the-art and emerging therapies","volume":"10","author":"Papadopoulos","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2017.07.014_bib21","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1468-1331.2010.03066.x","article-title":"EFNS guidelines on diagnosis and management of neuromyelitis optica","volume":"17","author":"Sellner","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2017.07.014_bib22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/135245859900500406","article-title":"The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis","volume":"5","author":"Sharrack","year":"1999","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2017.07.014_bib23","doi-asserted-by":"crossref","first-page":"A426","DOI":"10.1016\/j.jval.2011.08.1061","article-title":"A comparison of the patientslikeme quality of life questionnare (PLMQOL) with the RAND SF-36","volume":"14","author":"Slawsky","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.msard.2017.07.014_bib24","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archneur.63.7.957","article-title":"Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease)","volume":"63","author":"Weinstock-Guttman","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2017.07.014_bib25","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.2196\/jmir.1549","article-title":"Sharing health data for better outcomes on PatientsLikeMe","volume":"12","author":"Wicks","year":"2010","journal-title":"J. Med. Internet Res."},{"key":"10.1016\/j.msard.2017.07.014_bib26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1477-7525-10-70","article-title":"The multiple sclerosis rating scale, revised (MSRS-R): development, refinement, and psychometric validation using an online community","volume":"10","author":"Wicks","year":"2012","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.msard.2017.07.014_bib27","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2017.07.014_bib28","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2017.07.014_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034817301645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034817301645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:42:49Z","timestamp":1761900169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034817301645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":29,"alternative-id":["S2211034817301645"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2017.07.014","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient perspectives on neuromyelitis optica spectrum disorders: Data from the PatientsLikeMe online community","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2017.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}